Portfolio

We’re immensely proud of our portfolio. We partner with companies, often in the early stage, to build strong management teams and to ensure our CEOs and entrepreneurs have access to our network and resources to accelerate the advancement of their assets.

The MRCF plays an active, ‘hands on’ role, working closely with the Member Institutes to identify promising opportunities, ‘working them up’, completing due diligence, establishing the start-up company. Importantly, we then guide early-stage investments through the development process to a trade-sale, partnering, next round financing or into stand-alone, growing businesses.The MRCF invests in opportunities originating from its member medical research institutes or research hospitals. Each Member Institute selects a representative for the MRCF’s Investment Review Committee (IRC), the body which provides a peer review assessment of investment proposals.

To date, the MRCF has supported more than 40 promising start-up companies, with over 85 percent of them founded by the MRCF.

Aravax
Aravax

Creating the first safe and rapidly effective treatment for peanut allergy

View Project
Pathios Therapeutics
Pathios Therapeutics

Pathios Therapeutics is an early-stage drug discovery company headquartered in Oxford, UK.

View Project
George Medicines
George Medicines

George Medicines is an innovative late-stage drug development company focused on the large, expanding and underserved market for the management of non-communicable diseases (NCDs)

View Project
PolyActiva
PolyActiva

A clinical-stage biotechnology company focussed on the development of ocular implants

View Project
Certa Therapeutics
Certa Therapeutics

Developing novel anti-fibrotic therapies for the treatment of scarring associated with chronic kidney disease

View Project
Azura Ophthalmics
Azura Ophthalmics

Developing a novel therapy for the treatment of Meibomian Gland Dysfunction

View Project
Cincera Therapeutics
Cincera Therapeutics

Targeting fibrotic and inflammatory indications associated with type 2 diabetes and metabolic syndrome with an initial focus on liver fibrosis

View Project
EBR Systems
EBR Systems

Developing therapies for patients with cardiac rhythm diseases and heart failure using wireless cardiac stimulation

View Project
Ena Therapeutics
Ena Therapeutics

Developing therapies for respiratory infections in patients with asthma and COPD

View Project
Okogen
Okogen

Developing therapeutics for the treatment of ophthalmic diseases, including adenoviral conjunctivitis

View Project
OncoRes Medical
OncoRes Medical

Developing an imaging technology that will provide intraoperative information to surgeons to assist with the identification of tumour and healthy tissue

View Project
Q-Sera
Q-Sera

A proprietary blood collection tube rapidly providing high quality serum for analysis from all bloods including anti-coagulated

View Project